Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort

Affiliations

• ¹ UCSF Department of Dermatology and UC Berkeley Division of Epidemiology and Biostatistics, San Francisco, California. Electronic address: Katrina.Abuabara@ucsf.edu.
• ² Departments of Dermatology and Pediatrics, University of California San Diego, San Diego, California.
• ³ Innovaderm Research, Montreal, Quebec, Canada.
• ⁴ George Washington University, Washington, DC.
• ⁵ Eczema Treatment Center of New Jersey, New Jersey.
• ⁶ Ichan School of Medicine at Mount Sinai, The Kimberly and Eric J. Waldman Department of Dermatology, New York, New York.
• ⁷ University of Lübeck, Lübeck, Germany.
• ⁸ Department of Dermatology, Oregon Health and Science University, Portland, Oregon.
• ⁹ UMass Chan Medical School, Department of Dermatology, Worcester, Massachusetts.
• ¹⁰ Rockefeller University, New York, New York.
• ¹¹ Pfizer Inc., Collegeville, Pennsylvania.
• ¹² AbbVie, North Chicago, Illinois.
• ¹³ Novartis, Basel, Switzerland.
• ¹⁴ Target RWE, Durham, North Carolina.
• ¹⁵ Northwestern Feinberg School of Medicine, NMH/Arkes Family Pavilion, Chicago, Illinois.